AL-034
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-034, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants [Phase 1]